Drug Type Autologous CAR-T |
Synonyms AVA-001 |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Phase 1 | CN | 19 Sep 2019 | |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | CN | 19 Sep 2019 | |
B-Cell Malignant Neoplasm | Phase 1 | CN | 01 Aug 2019 | |
B-Cell Malignant Neoplasm | Phase 1 | CN | 01 Aug 2019 |